2,500
Participants
Start Date
March 11, 2024
Primary Completion Date
March 11, 2026
Study Completion Date
March 11, 2026
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening
All patients who participate in the trial will receive one of three social and behavioral determinants of health (SBDOH) screening instruments (AHC-HRSN, Health Leads, or NCCN DT + PL). Any patients who do not complete the screening within 48 hours of its administration will be randomized to receive the same screening via one of two modality arms (Chatbot or IVR System)
University of Pennsylvania, Philadelphia
Collaborators (1)
Gilead Sciences
INDUSTRY
Abramson Cancer Center at Penn Medicine
OTHER